Skip to content
Dipyrone
Dipyrone is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N02: Analgesics
N02B: Other analgesics and antipyretics in atc
N02BB: Pyrazolones, analgesics and antipyretics
N02BB02: Metamizole sodium
N02BB52: Metamizole sodium, combinations excl. psycholeptics
N02BB72: Metamizole sodium, combinations with psycholeptics
HCPCS
No data
Clinical
Clinical Trials
45 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149G89.18235515
PainD010146EFO_0003843R5211417
Cesarean sectionD00258533
NeuralgiaD009437EFO_000943022
Pain managementD05940811
AnesthesiaD00075811
Hip fracturesD006620EFO_0003964S72.0011
FeverD005334HP_0001945R50.911
Abdominal aortic aneurysmD017544EFO_000421411
Atherosclerotic plaqueD058226HP_0031678I7011
Show 3 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic painD059350HP_0012532112
Migraine disordersD008881EFO_0003821G4311
Spinal cord injuriesD013119EFO_100191911
GastroenteritisD005759EFO_1001463K52.911
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute painD059787R5211
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug interactionsD00434722
Healthy volunteers/patients11
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gingival recessionD005889K06.033
Postoperative nausea and vomitingD020250EFO_000488822
Vitreoretinal surgeryD05758622
AnalgesiaD00069822
Tooth abrasionD014072K03.122
Intervertebral disc degenerationD055959HP_000841911
Platelet aggregationD010974GO_007052711
CraniotomyD00339911
AnxietyD001007EFO_0005230F41.111
Chronic pancreatitisD050500EFO_0000342K86.111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIPYRONE
INNmetamizole sodium
Description
Metamizole sodium is an organic sodium salt of antipyrine substituted at C-4 by a methyl(sulfonatomethyl)amino group, commonly used as a powerful analgesic and antipyretic. It has a role as a non-narcotic analgesic, an antirheumatic drug, a peripheral nervous system drug, an antipyretic, a prodrug, a cyclooxygenase 3 inhibitor and an anti-inflammatory agent. It contains a metamizole(1-).
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]
Identifiers
PDB
CAS-ID68-89-3
RxCUI1537943
ChEMBL IDCHEMBL3989803
ChEBI ID
PubChem CID522325
DrugBankDB04817
UNII IDVSU62Z74ON (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2,167 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
20,411 adverse events reported
View more details